Skip to content

Application of dynamic blood glucose monitoring system in health management system of gestational diabetes mellitus

Application of CGMS in health management system of gestational diabetes mellitus based on multi omics Technology

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100043934
Enrollment
Unknown
Registered
2021-03-05
Start date
2021-03-30
Completion date
Unknown
Last updated
2021-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational Diabetes Mellitus

Interventions

CGMS :Wearing CGMS
Control :none

Sponsors

Peking Union Medical College Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 100 pregnant women with GDM and 50 healthy pregnant women were included and divided into three groups: 50 pregnant women with GDM wearing CGMS, 50 pregnant women without GDM wearing CGMS and 50 healthy pregnant women without CGMS. Inclusion criteria for GDM pregnant women: 1. 24-28 weeks GDM pregnant women (75g OGTT iadpsg diagnosis GDM (1) FPG >= 5.1 mmol / L or (2) 1H >= 10.0 mmol / L or (3) 2H >= 8.5 mmol / L); 2. Including caesarean section and natural birth; 3. 18.5 < BMI < 24.0kg/m2; 4. Gdma1 & gdma2; Inclusion criteria for healthy pregnant women: 1.75g OGTT iadpsg diagnosis non GDM; 2. Including caesarean section and natural birth; 3.18.5 < BMI < 24.0kg/m2.

Exclusion criteria

Exclusion criteria: 1. Twin or multiple; 2. Combined with other pregnancy diseases; 3. Combined with other diseases that may affect omics, including thyroid disease, inflammatory bowel disease, irritable bowel syndrome, celiac disease, pre pregnancy diabetes, etc.; 4. Had gastrointestinal and biliary surgery, including weight loss surgery, cholecystectomy, etc.; 5. Have a history of smoking, drinking and using narcotic drugs; 6. Long term medication history, taking oral drugs that may affect metabolism, including metformin, acarbose, betaine, antihypertensive drugs, aspirin, etc.; 7. Take drugs that affect intestinal flora, such as antibiotics, etc. in the past month, and eat probiotics, probiotics and other foods within one week; Exclusion criteria for healthy pregnant women High risk factors of GDM were excluded, including pre pregnancy obesity, type 2 diabetes mellitus in first degree relatives, GDM history, macrosomia delivery history, polycystic ovary syndrome, repeated positive fasting urine glucose in early pregnancy.

Design outcomes

Primary

MeasureTime frame
CGMS dynamic blood glucose data;Blood metabonomics;Blood protein chip;Intestinal bacteria in stool;

Secondary

MeasureTime frame
Blood biochemical indexes;urinalysis;Urine SO-PGE2;

Countries

China

Contacts

Public ContactYu Miao

Peking Union Medical College Hospital

yumiaoxh@163.com+86 18601255957

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026